Molecular Partners AG
MOLN· Nasdaq
Who holds Molecular Partners AG, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 2.2M | ±0% | $8.6M | 0.2% | Aug 14, 2026 |
| BVF Inc | 1.4M | ±0% | $5.1M | 0.1% | Aug 14, 2026 |
| Citadel Advisors LLC | 17.2K | New | $65.3K | 0% | Sep 2, 2026 |
| Morgan Stanley | 367 | ±0% | $1.4K | 0% | Aug 13, 2026 |
| UBS Group AG | 279 | New | $1.1K | 0% | Aug 13, 2026 |